Clinical Trial Update: Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating iberdomide in combination with low-dose cyclophosphamide and dexamethasone for multiple myeloma; the study is currently active…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DEXAMETHASONE (Dexamethasone)
• iberdomide (iberdomide)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING